Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Sales | 0 | 0 | 8 | 6 | 3 |
| Gross Profit | N/A | 0 | 8 | 6 | 3 |
| Operating Expenses | 316 | 23 | 185 | 1,149 | 1,891 |
| Operating Income | -316 | -23 | -177 | -1,143 | -1,888 |
| Interest Expense | 0 | 0 | 49 | 88 | 205 |
| Other Income | 0 | 0 | 0 | 229 | 874 |
| Pre-tax Income | -316 | -23 | -226 | -1,002 | -1,219 |
| Income Tax | N/A | 0 | N/A | 68 | 0 |
| Net Income Continuous | -316 | -23 | -226 | -1,070 | -1,219 |
| Net Income | $-316 | $-23 | $-226 | $-1,070 | $-1,219 |
| EPS Basic Total Ops | 0.00 | -119.75 | 0.00 | -0.04 | -0.31 |
| EPS Basic Continuous Ops | -0.35 | -119.75 | 0.00 | -0.04 | -0.13 |
| EPS Diluted Total Ops | 0.00 | -119.75 | 0.00 | -0.04 | -0.31 |
| EPS Diluted Continuous Ops | -0.35 | -119.75 | 0.00 | -0.04 | -0.13 |
| EBITDA(a) | $-316 | $-23 | $-153 | $-1,110 | $-1,854 |